Global life sciences company Univercells Technologies is interested in teaming up with the Department of Trade and Industry for the roll-out of the Vaccine Self Reliance Program and the development of the Virology Institute of the Philippines.
Trade Secretary Alfredo Pascual said the collaboration with the Belgian biotechnology company would contribute to the Philippines’ goal of achieving vaccine self-reliance and advancing the field of virology within the country.
“One of the top priorities of the Philippines in terms of gathering investments is the manufacturing of vaccines and biologics, which is part of our health and life sciences priority cluster. With this, we aim to establish security in addressing current and future health emergences and pandemics. And this can be done if the country will be able to position itself as a manufacturing hub for vaccines,” said Pascual. Univercells’ Quantoom enable the efficient production of vaccines at a smaller scale. By downsizing traditional manufacturing processes, Univercells democratizes vaccine production by equipping developing countries with the tools to establish local vaccine production facilities tailored to their specific needs.
